Stroke therapy.
University of California, San Diego, School of Medicine.
J A
JA
Zivin
D W
DW
Choi
D000818:Animals; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000628:therapy; D002118:Calcium / Q000378:metabolism; D002470:Cell Survival; D002539:Cerebral Arterial Diseases / Q000150:complications / Q000628:therapy; D002561:Cerebrovascular Disorders / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D016291:Dizocilpine Maleate / Q000627:therapeutic use; D018691:Excitatory Amino Acid Antagonists; D005971:Glutamates / Q000378:metabolism; D018698:Glutamic Acid; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000150:complications / Q000628:therapy; D009474:Neurons / Q000502:physiology; D010875:Pipecolic Acids / Q000627:therapeutic use; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000502:physiology; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014055:Tomography, Emission-Computed
D018691:Excitatory Amino Acid Antagonists; D005971:Glutamates; D010875:Pipecolic Acids; D016194:Receptors, N-Methyl-D-Aspartate; D018698:Glutamic Acid; C053672:selfotel; D016291:Dizocilpine Maleate; D010959:Tissue Plasminogen Activator; D002118:Calcium